{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":22,"mapped":1},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P16410","source":"P16410|Cytotoxic T-lymphocyte protein 4","targets":["1AH1|CTLA-4, NMR, 20 STRUCTURES|SOLUTION NMR||Homo sapiens|0|IMMUNORECEPTOR","1H6E|MU2 ADAPTIN SUBUNIT (AP50) OF AP2 ADAPTOR (SECOND DOMAIN), COMPLEXED WITH CTLA-4 INTERNALIZATION PEPTIDE TTGVYVKMPPT|X-RAY DIFFRACTION|3.6|HOMO SAPIENS; SYNTHETIC CONSTRUCT|0|ENDOCYTOSIS/EXOCYTOSIS","1I85|CRYSTAL STRUCTURE OF THE CTLA-4/B7-2 COMPLEX|X-RAY DIFFRACTION|3.2|Homo sapiens|0|IMMUNE SYSTEM","1I8L|HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX|X-RAY DIFFRACTION|3|Homo sapiens|0|IMMUNE SYSTEM","2X44|Structure of a strand-swapped dimeric form of CTLA-4|X-RAY DIFFRACTION|2.6|HOMO SAPIENS|0|IMMUNE SYSTEM","3BX7|Engineered Human Lipocalin 2 (LCN2) in Complex with the Extracellular Domain of Human CTLA-4|X-RAY DIFFRACTION|2.1|Homo sapiens|0|DE NOVO PROTEIN, PROTEIN BINDING","3OSK|Crystal structure of human CTLA-4 apo homodimer|X-RAY DIFFRACTION|1.8|Homo sapiens|0|IMMUNE SYSTEM","5GGV|CTLA-4 in complex with tremelimumab Fab|X-RAY DIFFRACTION|1.998|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","5TRU|Structure of the first-in-class checkpoint inhibitor Ipilimumab bound to human CTLA-4|X-RAY DIFFRACTION|3|Homo sapiens|0|IMMUNE SYSTEM","5XJ3|Complex structure of ipilimumab-scFv and CTLA-4|X-RAY DIFFRACTION|3.2|Homo sapiens|0|IMMUNE SYSTEM","6RP8|Crystal Structure of Ipilimumab Fab complexed with CTLA-4 at 2.6A resolution|X-RAY DIFFRACTION|2.6|Homo sapiens|0|IMMUNE SYSTEM","6RPJ|A Non-blocking anti-CTLA-4 Nanobody complexed with CTLA-4|X-RAY DIFFRACTION|3.25|Camelus bactrianus; Homo sapiens|0|IMMUNE SYSTEM","6RQM|A blocking anti-CTLA-4 Nanobody (KN044) complexed with CTLA-4|X-RAY DIFFRACTION|3|Camelus bactrianus; Homo sapiens|0|IMMUNE SYSTEM","6XY2|Crystal structure of CTLA-4 complexed with the Fab of HL32 antibody|X-RAY DIFFRACTION|3.05|Homo sapiens|0|IMMUNE SYSTEM","7CIO|Molecular interactions of cytoplasmic region of CTLA-4 with SH2 domains of PI3-kinase|X-RAY DIFFRACTION|1.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN","7DV4|Crystal structure of anti-CTLA-4 VH domain in complex with human CTLA-4|X-RAY DIFFRACTION|2.38|Homo sapiens|0|IMMUNE SYSTEM","7ELX|The crystal structure of CTLA-4 and Fab|X-RAY DIFFRACTION|2.14|Homo sapiens|0|APOPTOSIS","7SU0|Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.105 in complex with CTLA-4|X-RAY DIFFRACTION|2.41|Homo sapiens|0|IMMUNE SYSTEM","7SU1|Crystal structure of an acidic pH-selective Ipilimumab variant Ipi.106 in complex with CTLA-4|X-RAY DIFFRACTION|2.53|Homo sapiens|0|IMMUNE SYSTEM","8GAB|Crystal structure of CTLA-4 in complex with a high affinity CTLA-4 binder|X-RAY DIFFRACTION|2.72|Homo sapiens; synthetic construct|0|DE NOVO PROTEIN/Immune System","8HIT|Crystal structure of anti-CTLA-4 humanized IgG1 MAb--JS007 in complex with human CTLA-4|X-RAY DIFFRACTION|3.2|Homo sapiens; Mus musculus|0|IMMUNE SYSTEM","9DQ3|Crystal structure of engineered Ipilimumab (mipi.4) Fab in complex with human CTLA-4|X-RAY DIFFRACTION|1.64|Homo sapiens|0|ANTITUMOR PROTEIN/IMMUNE SYSTEM"]}]}